5 Einträge gefunden

1. Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma

   1. Facon, Thierry
   2. Kumar, Shaji K
   3. Plesner, Torben
   4. Orlowski, Robert Z
   5. Moreau, Philippe
   6. Bahlis, Nizar
   7. Basu, Supratik

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA

   1. Facon, Thierry
   2. Cook, Gordon
   3. Usmani, Saad Z
   4. Hulin, Cyrille
   5. Kumar, Shaji
   6. Plesner, Torben
   7. Touzeau, Cyrille

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial

   1. Facon, Thierry
   2. Kumar, Shaji K
   3. Plesner, Torben
   4. Orlowski, Robert Z
   5. Moreau, Philippe
   6. Bahlis, Nizar
   7. Basu, Supratik

   2021 - Forschungsinformationssystem des UKE
4. Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

   1. Weisel, Katja
   2. Dimopoulos, Meletios
   3. Moreau, Philippe
   4. Yagci, Munci
   5. Larocca, Alessandra
   6. Kanate, Abraham S
   7. Vural, Filiz

   2020 - Forschungsinformationssystem des UKE
5. Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

   1. Facon, Thierry
   2. Kumar, Shaji
   3. Plesner, Torben
   4. Orlowski, Robert Z
   5. Moreau, Philippe
   6. Bahlis, Nizar
   7. Basu, Supratik

   2019 - Forschungsinformationssystem des UKE